论文部分内容阅读
一、降脂药引起的肾损害1·羟甲戊二酰辅酶A还原酶抑制剂(HMG-CoA还原酶抑制剂:他汀类)与糖尿病、高血压一样,高脂血症是动脉硬化性疾病和慢性肾病进展的重要促进因子,其治疗的重要性已得到广泛认同。无论是从迄今为止的临床试验和各国长期使用的经验,还是根据流行病学的调查结
First, lipid-lowering drug-induced renal damage 1 hydroxymethyl glutaryl coenzyme A reductase inhibitors (HMG-CoA reductase inhibitors: statins) and diabetes, hypertension, hyperlipidemia is atherosclerotic disease And the important promotion factors of the progress of chronic kidney disease, the importance of its treatment has been widely accepted. Whether from the clinical trials to date and the long-term experience of countries, or based on epidemiological findings